Financials
Financial year 2025
SOLVUS from Gent, company number BE0771457727, closed financial year 2025 with a result of € 170,841 after tax. For that financial year SOLVUS recorded a gross margin of € 492,034 and equity of € 406,905. Compared with financial year 2024, the result moved from € 862,295 to € 170,841. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 12, 2026.
€ 406,905
▲ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 170,841
▼ 80% vs 2024
Profit after tax over the fiscal year.
€ 2.4 million
▲ € 1.9 million vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
59 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 202,632
▲ 117% vs 2024
€ 202,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 40,646
▲ 195% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 91,428
▲ 26% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 96,905 | € 177,139 | € 414,430 | € 492,034 | ▲ 19% |
| Profit after taxes | € 66,570 | € 54,199 | € 862,295 | € 170,841 | ▼ 80% |
| Equity | € 69,570 | € 123,769 | € 336,064 | € 406,905 | ▲ 21% |
| Total debts | € 618,171 | € 846,138 | € 1,090,142 | € 2,093,949 | ▲ 92% |
| Cash | € 86,283 | € 37,439 | € 482,765 | € 2,371,093 | ▲ € 1.9 million |
| Retained profit | € 66,570 | € 120,769 | € 333,064 | € 403,905 | ▲ 21% |
| Dividend | € 0 | € 0 | € 650,000 | € 100,000 | ▼ 85% |
| Bank debt | € 0 | € 400,000 | € 600,000 | € 0 | ▼ 100% |
| Balance sheet total | € 687,741 | € 969,907 | € 1,426,206 | € 2,500,854 | ▲ 75% |
| Employees (FTE) | - | 1 | 1 | 1 |
Key figures of SOLVUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOLVUS?
What happened at SOLVUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 170,841 (▼ 80% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Tom De Gres became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 66,570 profit in 2022 to € 170,841 profit in 2025.
Paid € 170,170 in corporate taxes since 2022.
Best year ever: 2024, with € 862,295 profit.
On average € 492,000 of value added per employee in 2025.
Management
The stake of United NRJ comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SOLVUSBehind SOLVUS is Tom De Gres. The shares are held by United NRJ (43%).
Directors
According to the 2025 annual accounts
Tom De Gres
Director
Also active at: Ace, SAVERDE, International Platform for Art Research & Conservation, FoodCheck, Taikun Pharmaceutical Technology
since 2021
Shareholders
43%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82 L 13
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0771.457.727
- VAT number
- BE 0771.457.727
- Registered office
- Technologiepark-Zwijnaarde 82 L 13, 9052 Gent
- Names & denominations
- SOLVUS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 2021
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Overige zakelijke dienstverlening, neg
Groothandel in farmaceutische en medische artikelen